The phase 1/2 ONE-SHOT study assessed a single-fraction of high-dose SBRT for early biochemical disease control and safety in localized prostate cancer.

Prostate cancer affects 1 in 8 men, but experts say it’s highly treatable when caught early. A survivor shares how PSA ...

New research suggests that low handgrip strength alone is not a reliable predictor of increased prostate cancer risk among ...

Daniel W. Lin, MD, reviews new guidance on using MRI, biomarkers, and more, to improve the detection of prostate cancer.

Doctors say men should not wait for symptoms to ask about prostate cancer screening.

Know the 8 prostate cancer symptoms to watch for, from urinary changes to bone pain, plus who is most at risk and when to get ...

Adding apalutamide to ADT in the adjuvant and neoadjuvant settings improves outcomes in prostate cancer patients undergoing radical prostatectomy.

Men treated for prostate cancer after surgery now have clearer evidence that extending hormone therapy from six months to two ...

For decades, the sugar content in fruit juices has been blamed for causing blood glucose spikes that are linked to weight ...

Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing arrangement with LifeMD for the XYOSTED self-pay program, l ...

Niamh Shackleton is an experienced journalist for UNILAD, specialising in topics including mental health and showbiz, as well as anything Henry Cavill and cat related. She has previously worked for OK ...

The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million ...